Mercer Global Advisors
IRWD icon

Mercer Global Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mercer Global Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$404K Buy
115,080
+38,129
+50% +$156K ﹤0.01% 2162
2025
Q4 		$259K Buy
76,951
+5,598
+8% +$14.5K ﹤0.01% 2350
2025
Q3 		$93.5K Buy
71,353
+37,938
+114% +$39.3K ﹤0.01% 2527
2025
Q2 		$24K Buy
+33,415
New +$26.2K ﹤0.01% 2221
2024
Q4 		– Sell
-15,316
Closed -$61.6K – 2192
2024
Q3 		$61.6K Sell
15,316
-1,287
-8% -$6.92K ﹤0.01% 1907
2024
Q2 		$108K Sell
16,603
-219,620
-93% -$1.55M ﹤0.01% 1867
2024
Q1 		$2.06M Sell
236,223
-4,211
-2% -$51.1K 0.01% 719
2023
Q4 		$2.75M Sell
240,434
-4,315
-2% -$42.7K 0.01% 635
2023
Q3 		$2.36M Buy
244,749
+34,737
+17% +$340K 0.01% 649
2023
Q2 		$2.23M Buy
210,012
+20,610
+11% +$222K 0.01% 698
2023
Q1 		$1.99M Buy
189,402
+10,366
+6% +$116K 0.01% 684
2022
Q4 		$2.22M Buy
179,036
+1,906
+1% +$21.6K 0.01% 662
2022
Q3 		$1.83M Buy
177,130
+1,659
+0.9% +$18.8K 0.01% 643
2022
Q2 		$2.02M Buy
175,471
+19,422
+12% +$229K 0.01% 609
2022
Q1 		$1.96M Buy
156,049
+31,432
+25% +$360K 0.01% 653
2021
Q4 		$1.45M Buy
124,617
+63,100
+103% +$774K 0.01% 735
2021
Q3 		$803K Buy
61,517
+13,079
+27% +$169K 0.01% 965
2021
Q2 		$623K Buy
48,438
+2,550
+6% +$29.2K ﹤0.01% 1039
2021
Q1 		$513K Sell
45,888
-1,554
-3% -$16.4K ﹤0.01% 1069
2020
Q4 		$540K Buy
47,442
+10,401
+28% +$114K 0.01% 834
2020
Q3 		$333K Buy
37,041
+1,484
+4% +$14.7K 0.01% 919
2020
Q2 		$367K Buy
+35,557
New +$364K 0.01% 784

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mercer Global Advisors's IRWD Position: Q1 2026 in Review

Mercer Global Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 50% in Q1 2026, buying an estimated $156K and bringing the position to 115,080 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #2162.

Mercer Global Advisors first reported a position in IRWD in Q2 2020 and has held it in 22 quarters since. The position peaked at $2.75M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Mercer Global Advisors held 115,080 shares of Ironwood Pharmaceuticals worth $404K as of Q1 2026.
  • Mercer Global Advisors bought 38,129 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $156K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2162 holding.
  • Mercer Global Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
  • Mercer Global Advisors's Ironwood Pharmaceuticals position peaked at $2.75M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.